Schedule 13G ownership disclosure

Propanc Biopharma, Inc.

Security class unavailable · CUSIP: 74346N206

Event date: 2020-07-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
14,032,648
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-20-016899
Form type
SC 13G
Filer
Oasis Capital, LLC
CIK
CIK 1771926
Filed
Jul 07, 2020
Reporting period
Jul 07, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub